FDA.reportPublic FDA data

zenocutuzumab-zbco 375 MG per 18.75 ML Injection

RxCUI
2699594
RxNorm name
zenocutuzumab-zbco 375 MG per 18.75 ML Injection
Display name
zenocutuzumab-zbco 375 MG per 18.75 ML Injection
Full name
zenocutuzumab-zbco 375 MG per 18.75 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761352Bizengrizenocutuzumab-zbco351(a)Rx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BIZENGRIZENOCUTUZUMABPartner Therapeutics, Inc.203daea4-fc87-40a4-a92f-ba2351b16de12026-05-19Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2699594
BIZENGRIZENOCUTUZUMABMerus US, Inc.2a33e782-fc75-4dba-b77c-a44536ac13a52025-01-17Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2699594

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
203daea4-fc87-40a4-a92f-ba2351b16de1zenocutuzumab-zbco 375 MG in 18.75 ML Injection [PSN] · 18.75 ML zenocutuzumab-zbco 20 MG/ML Injection [SCD] · zenocutuzumab-zbco 375 MG per 18.75 ML Injection [SY]33These highlights do not include all the information needed to use BIZENGRI® safely and effectively. See full prescribing information for BIZENGRI. BIZENGRI (zenocutuzumab-zbco) injection, for intravenous use Initial U.S. Approval: 202420260519
2a33e782-fc75-4dba-b77c-a44536ac13a5zenocutuzumab-zbco 375 MG in 18.75 ML Injection [PSN] · 18.75 ML zenocutuzumab-zbco 20 MG/ML Injection [SCD] · zenocutuzumab-zbco 375 MG per 18.75 ML Injection [SY]32These highlights do not include all the information needed to use BIZENGRI® safely and effectively. See full prescribing information for BIZENGRI. BIZENGRI (zenocutuzumab-zbco) injection, for intravenous use Initial U.S. Approval: 202420250117